Euglycemic Ketoacidosis in Patients Without Diabetes After Introduction of SGLT2 Inhibitor for HFrEF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium-Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction
Diabetes Care 2024 Jan 01;47(1)140-143, MM Umapathysivam, J Gunton, SN Stranks, D JesudasonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.